First Marblehead's Third Quarter Results From Operations

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
First Marblehead's Third Quarter Results From Operations Improve 23% Year-Over-Year; Net Operating Cash Usage* Reduced 36%

BOSTON, MA--(Marketwired - Apr 29, 2013) - The First Marblehead Corporation ( NYSE : FMD ) today announced its financial and operating results for the third quarter of fiscal 2013 as well as the nine month period ended March 31, 2013. Results for the nine months ended March 31, 2013 included facilitated loan volumes, income and expenses of our subsidiary Cology LLC ("Cology") since October 19, 2012. 

Total facilitated loan volumes for the quarter ended March 31, 2013 were $68.8 million, including $52.9 million facilitated by Cology. Monogram ® -based facilitated loan volumes for the quarter totaled $15.9 million, up $6.4 million, or 67%, from the same period a year ago. For the nine months ended March 31, 2013, total facilitated loan volumes were $220.2 million, including $117.6 million of Monogram-based loans, an increase of 122% year-over-year. Loan disbursements totaled $394.6 million, including $120.7 million of Monogram-based loans for the nine months ended March 31, 2013.

"We believe that the solid growth in loan disbursements and the continued decline in net operating cash usage are indicators of the significant improvements made to First Marblehead's operating results since last year," said Daniel Meyers, Chairman and Chief Executive Officer. "In addition, we are now on the lender lists of approximately 1,000 educational institutions, which we believe positions us for a solid upcoming peak lending season," added Mr. Meyers.

For the third quarter of fiscal 2013, the Company recorded a loss from operations of $8.8 million compared to a loss from operations of $11.4 million for the third quarter of fiscal 2012, an improvement of 23%. The net loss from continuing operations for the third quarter of fiscal 2013 was $8.8 million, or ($0.08) per common share, compared to net income from continuing operations of $2.9 million, or $0.03 per fully diluted common share for the same period a year ago. However, the results from the third quarter of fiscal 2012 included $14.4 million of benefits related to the deconsolidation of the GATE trusts and the resulting income tax allocations for the discontinued operations presentation. Revenues fell $1.0 million to $12.8 million for the quarter ended March 31, 2013 as the results for the quarter ended March 31, 2012 included $1.6 million in higher fair value changes to service revenue receivables. This decrease was partially offset by $0.8 million in higher administrative fee income for the quarter ended March 31, 2013 as a result of higher Monogram-based loan originations. In addition, Company expenses fell 14% from $25.1 million in the third quarter of fiscal 2012 to $21.6 million for the third quarter of fiscal 2013 primarily as a result of lower professional fees ($0.8 million), lower special servicing costs ($1.3 million) and lower compensation costs ($0.8 million).

For the nine months ended March 31, 2013, the Company recorded a loss from operations of $34.6 million compared to a loss from operations of $48.0 million for the same period a year ago, an improvement of 28%. For the nine months ended March 31, 2013, revenues increased 16% primarily as a result of $1.1 million in higher net interest income after provision for loan losses and $2.1 million in increased administrative and other fee revenues principally from Monogram-based loan originations. In addition, overall expense levels declined approximately 10%, or $8.3 million, for the nine months ended March 31, 2013 compared to the same period a year ago, as the Company continued to execute on its cost reduction efforts.

The net loss from continuing operations for the nine months ended March 31, 2013 was $35.0 million, or ($0.33) per common share, compared to a net loss from continuing operations of $19.6 million, or ($0.18) per common share, for the same period a year ago. Similar to the quarterly results for the period ended March 31, 2012, the nine month period ended March 31, 2012 included significant benefits related to the deconsolidation of the GATE trusts as well as an income tax benefit from continuing operations that in the aggregate totaled $27.0 million over that period.

Company Liquidity

As of March 31, 2013, the Company had $191.6 million in cash, cash equivalents and short-term investments compared to $182.5 million at December 31, 2012.

The increase of $9.1 million from the prior quarter resulted primarily from the $37.5 million growth in deposits, net of investments in private education loans and investments available-for-sale at Union Federal Savings Bank of $15.4 million, partially offset by $7.9 million of net operating cash usage to fund operations. The net operating cash usage of $7.9 million was 36% lower than the quarter ended March 31, 2012 and represents the lowest quarterly net operating cash usage since the Company began reporting this metric in the second quarter of fiscal 2009.

Net operating cash usage for the nine months ended March 31, 2013 was $32.4 million, a $9.2 million, or 22%, reduction compared to the same nine month period a year ago.

* See below under the heading "Use of Non-GAAP Financial Measures."

Quarterly Conference Call

First Marblehead will host a conference call on Monday, April 29, 2013 at 5:00 p.m. Eastern time to discuss its operating results. Investors and other interested parties are invited to listen to the conference call via a simultaneous internet broadcast on the Company's website at www.firstmarblehead.com , under "For Investors," or by dialing (888) 317-6003 from the United States or (412) 317-6061 from abroad and entering the pass code 9866432.

A replay will be available approximately one hour after completion of the call on First Marblehead's website or by dialing (877) 344-7529 from the United States or (412) 317-0088 from abroad and entering the pass code 10028091. The replay will be available for two weeks.

About The First Marblehead Corporation First Marblehead helps meet the need for education financing by offering national and regional financial institutions and educational institutions the Monogram ® platform, an integrated suite of design, implementation and credit risk management services for private label, customizable private education loan programs. For more information, please see www.firstmarblehead.com . First Marblehead supports responsible lending and is a strong proponent of the smart borrowing principle, which encourages students to access scholarships, grants and federally-guaranteed loans before considering private education loans; please see www.SmartBorrowing.org . Through its subsidiary, Union Federal Savings Bank, First Marblehead offers private education loans, residential and commercial mortgage loans and retail savings, money market and time deposit products. For more information, please see www.unionfsb.com . First Marblehead also offers outsourced tuition planning, billing, payment technology services and refund management services through its subsidiary Tuition Management Systems LLC. For more information, please see www.afford.com . Through its subsidiary, Cology LLC, First Marblehead offers private education loan processing and disbursement services as well as life-of-loan servicing for lenders. For more information, please see www2.cology.com .

Statements in this press release, including the financial tables, regarding First Marblehead's future financial and operating results and liquidity, including the characteristics, pricing or performance of future Monogram-based private education loan portfolios, and our expectations as to future financial success, as well as any other statements that are not purely historical, constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon our historical performance, and on our plans, estimates and expectations as of April 29, 2013. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future results, plans, estimates, intentions or expectations expressed or implied by us will be achieved. You are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, legislative, regulatory, competitive and other factors, which may cause our actual financial or operating results, facilitated loan volumes and resulting cash flows or financing-related revenues, or the timing of events, to be materially different than those expressed or implied by forward-looking statements. Important factors that could cause or contribute to such differences include: market acceptance of, and demand for, our Monogram platform and fee-based service offerings, including our success in negotiating loan program agreements with additional clients; the successful sales and marketing of Monogram-based loan offerings, including the volume of loan applications and the extent to which loan applications ultimately result in disbursed loans; the volume, timing and performance of disbursed loans; the size and structure of any credit enhancement provided by First Marblehead in connection with our Monogram platform; our success in designing, implementing and commercializing private education loan programs through Union Federal, including receipt of and compliance with regulatory approvals and conditions with respect to such programs; the successful sales and marketing of the products and services offered by TMS and Cology LLC; capital markets conditions and our ability to structure securitizations or alternative financings; the size, structure and timing of any such securitizations or alternative financings; any investigation, audit, claim, regulatory action or suit relating to the transfer of the trust certificate of NC Residuals Owners Trust or the asset services agreement between the purchaser and First Marblehead, including any challenge to tax refunds previously received as a result of the audit being conducted by the Internal Revenue Service; resolution of litigation and regulatory proceedings pertaining to our Massachusetts state income tax returns; our success in integrating the operations of Cology LLC and realizing the anticipated benefits of our acquisition of a substantial portion of the operating assets of Cology, Inc., including additional fee-based revenues; the estimates and assumptions we make in preparing our financial statements, including quantitative and qualitative factors used in determining the estimate of the fair value of service revenue receivables; and the other factors set forth under the caption "Part I - Item 1A. Risk Factors" in First Marblehead's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on February 8, 2013. Important factors that could cause or contribute to future adjustments to the estimates and assumptions we make in preparing our financial statements include: actual transactions or market observations relating to asset-backed securities, loan portfolios or corporate debt securities; variance between our performance assumptions and the actual performance of the loan portfolios held by the GATE trusts, Union Federal or First Marblehead's clients (the "Portfolios"); economic, legislative, regulatory, competitive and other factors affecting discount, default, recovery and prepayment rates on the Portfolios, including general economic conditions, the consumer credit environment and unemployment rates; management's determination of which qualitative and quantitative factors should be weighed in our estimates, and the weight to be given to such factors; capital markets receptivity to securities backed by private education loans; and interest rate trends. We specifically disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release, even if our estimates change, and you should not rely on those statements as representing our views as of any date subsequent to the date of this press release.

 
First Marblehead Corporation and Subsidiaries
Consolidated Statements of Operations
For the Three and Nine Months Ended March 31, 2013 and 2012
(unaudited)
(dollars and shares in thousands, except per share amounts)
 
                         
    Three months ended March 31,     Nine months ended March 31,  
    2013     2012     2013     2012  
Revenues:                                
  Net interest income:                                
    Interest income   $ 1,527     $ 950     $ 4,087     $ 2,230  
    Interest expense     (406 )     (209 )     (1,020 )     (679 )
      Net interest income     1,121       741       3,067       1,551  
  (Provision) credit for loan losses     (70 )     222       50       476  
      Net interest income after (provision) credit for loan losses     1,051       963       3,117       2,027  
Non-interest revenues:                                
    Tuition payment processing fees     7,466       7,697       22,264       22,172  
    Administrative and other fees     3,437       2,604       9,238       7,102  
    Fair value changes to service revenue receivables     838       2,454       2,057       202  
      Total non-interest revenues     11,741       12,755       33,559       29,476  
      Total revenues     12,792       13,718       36,676       31,503  
Non-interest expenses:                                
    Compensation and benefits     10,454       11,307       29,663       32,396  
    General and administrative     11,172       13,816       41,573       47,128  
      Total non-interest expenses     21,626       25,123       71,236       79,524  
Loss from operations     (8,834 )     (11,405 )     (34,560 )     (48,021 )
Other income:                                
    Gain from deconsolidation of trusts     --       9,156       --       9,514  
    Proceeds from TERI Settlement     421       --       702       1,405  
      Total other income     421       9,156       702       10,919  
Loss from continuing operations, before income taxes     (8,413 )     (2,249 )     (33,858 )     (37,102 )
Income tax expense (benefit) from continuing operations     376       (5,197 )     1,146       (17,489 )
(Loss) income from continuing operations     (8,789 )     2,948       (35,004 )     (19,613 )
Discontinued operations, net of taxes     --       6,910       --       1,135,781  
Net (loss) income   $ (8,789 )   $ 9,858     $ (35,004 )   $ 1,116,168  
  Net (loss) income per basic common share:                                
    From continuing operations   $ (0.08 )   $ 0.03     $ (0.33 )   $ (0.18 )
    From discontinued operations     --       0.06       --       10.30  
      Total basic net (loss) income per share   $ (0.08 )   $ 0.09     $ (0.33 )   $ 10.12  
  Net (loss) income per diluted common share:                                
    From continuing operations   $ (0.08 )   $ 0.03     $ (0.33 )   $ (0.18 )
    From discontinued operations     --       0.06       --       10.28  
      Total diluted net (loss) income per share   $ (0.08 )   $ 0.09     $ (0.33 )   $ 10.10  
    Weighted-average common shares outstanding:                                
      Basic     111,110       101,554       105,988       101,459  
      Diluted     111,110       110,573       105,988       110,499  
                                       
                                       
 
The First Marblehead Corporation and Subsidiaries
Consolidated Balance Sheets
As of March 31, 2013 and June 30, 2012
(unaudited)
(dollars and shares in thousands, except per share amounts)
 
             
    March 31, 2013     June 30, 2012  
Assets                
Cash and cash equivalents   $ 141,534     $ 123,497  
Short-term investments, at cost     50,116       85,007  
Restricted cash     36,641       65,401  
Investments available-for-sale, at fair value     83,898       68,598  
Education loans held-to-maturity, net of allowance of $1,546 and $1,309     62,082       33,095  
Mortgage loans held-to-maturity, net of allowance of $642 and $591     11,529       7,811  
Deposits for participation interest accounts, at fair value     10,847       4,039  
Service revenue receivables, at fair value     15,655       16,341  
Goodwill     20,066       19,548  
Intangible assets, net     24,808       20,922  
Property and equipment, net     5,947       4,570  
Other assets     10,208       8,976  
    Total assets   $ 473,331     $ 457,805  
                 
Liabilities and Stockholders' Equity                
Liabilities:                
  Deposits   $ 164,219     $ 83,428  
  Restricted funds due to clients     76,288       104,981  
  Accounts payable, accrued expenses and other liabilities     11,732       18,133  
  Income taxes payable     24,647       23,414  
  Net deferred income tax liability     1,181       861  
    Total liabilities     278,067       230,817  
Commitments and contingencies:                
Stockholders' equity:                
Preferred stock, par value $0.01 per share; 20,000 shares authorized; 0 and 133 shares issued and outstanding     --       1  
Common stock, par value $0.01 per share; 250,000 shares authorized; 119,867 and 110,658 shares issued; 111,110 and 102,002 shares outstanding     1,198       1,106  
Additional paid-in capital     455,857       452,726  
Accumulated deficit     (75,631 )     (40,627 )
Treasury stock, 8,757 and 8,656 shares held, at cost     (186,930 )     (186,828 )
Accumulated other comprehensive income     770       610  
    Total stockholders' equity     195,264       226,988  
    Total liabilities and stockholders' equity   $ 473,331     $ 457,805  
                     
                 
 
The First Marblehead Corporation and Subsidiaries
Facilitated and Disbursed Loan Volume Data
For the Three and Nine Months Ended March 31, 2013 and 2012
(unaudited)
(dollars in thousands)
 

The following tables present our loan volume metrics with respect to our Monogram-based loan programs for the three and nine months ended March 31, 2013 and 2012, as well as the private education loans processed by Cology for the period since the date of acquisition through March 31, 2013:

     
    Three months ended March 31,
    2013   2012
    Partnered Lending   Union Federal   Monogram Loan Programs Total   Cology LLC   Total   Partnered Lending   Union Federal   Monogram Loan Programs Total
    (dollars in thousands)
Facilitated Loans   $ 12,182   $ 3,713   $ 15,895   $ 52,916   $ 68,811   $ 2,268   $ 7,238   $ 9,506
Disbursed Loans     40,064     12,462     52,526     215,596     268,122     8,262     14,464     22,726
                       
  Nine months ended March 31,
  2013   2012
  Partnered Lending   Union Federal   Monogram Loan Programs Total   Cology LLC   Total   Partnered Lending   Union Federal   Monogram Loan Programs Total
  (dollars in thousands)
Facilitated Loans $ 88,474   $ 29,100   $ 117,574   $ 102,650   $ 220,224   $ 20,081   $ 32,809   $ 52,890
Disbursed Loans   89,270     31,409     120,679     273,896     394,575     20,572     31,683     52,255
                                               

Use of Non-GAAP Financial Measures

In addition to providing financial measurements based on U.S. generally accepted accounting principles ("GAAP"), the Company has included in this press release an additional financial metric that it refers to as "net operating cash usage" and that was not prepared in accordance with GAAP. The Company defines "net operating cash usage" to approximate cash required to fund its operations. "Net operating cash usage" is not directly comparable to the Company's consolidated statement of cash flows prepared in accordance with GAAP. Legislative and regulatory guidance discourages the use of, and emphasis on, non-GAAP financial metrics and requires companies to explain why a non-GAAP financial metric is relevant to management and investors.

The Company's management and its board of directors use this non-GAAP financial metric, in addition to GAAP financial measures, as a basis for measuring and forecasting the Company's core operating performance and comparing such performance to that of prior periods. The non-GAAP financial measure is also used by the Company in its financial and operational decision-making.

The Company believes that the inclusion of this non-GAAP financial metric helps investors to gain a better understanding of its results, including its non-interest expenses and liquidity position. In addition, the Company's presentation of this non-GAAP financial measure is consistent with how it expects that analysts may calculate their estimates of its financial results in their research reports and with how clients, investors, analysts and financial news media may evaluate its financial results.

There are limitations associated with reliance on any non-GAAP financial measure because any such measure is specific to the Company's operations and financial performance, which makes comparisons with other companies' financial results more challenging. Nevertheless, by providing both GAAP and non-GAAP financial measures, the Company believes that investors are able to compare its GAAP results to those of other companies, while also gaining a better understanding of its operating performance, consistent with management's evaluation.

"Net operating cash usage" should be considered in addition to, and not as a substitute for, or superior to, financial information prepared in accordance with GAAP. "Net operating cash usage" excludes the effects of income taxes, acquisitions or divestitures, participation interest account net fundings and changes in other assets and other liabilities that are solely related to short-term timing of cash payments or receipts.

 In accordance with the requirements of Regulation G promulgated by the Securities and Exchange Commission, the table below presents the most directly comparable GAAP financial measure, loss from continuing operations, before income taxes, for the three and nine months ended March 31, 2013 and 2012 and reconciles the GAAP measure to the comparable non-GAAP financial metric:

 
The First Marblehead Corporation and Subsidiaries
Net Operating Cash Usage, a non-GAAP Financial Measure
For the Three and Nine Month Periods Ended March 31, 2013 and 2012
(unaudited)
(dollars in thousands)
 
             
    Three months ended March 31,     Nine months ended March 31,  
    2013     2012     2013     2012  
Loss from continuing operations, before income taxes   $ (8,413 )   $ (2,249 )   $ (33,858 )   $ (37,102 )
Adjustments to net loss from continuing operations, before income taxes:                                
  Non-cash gain from deconsolidation of trusts     --       (9,156 )     --       (9,514 )
  Fair value changes to service revenue receivables     (838 )     (2,454 )     (2,057 )     (202 )
  Cash receipts from service revenue receivables     1,187       520       2,743       575  
  Depreciation and amortization     1,165       1,138       3,159       3,635  
  Stock-based compensation     1,072       1,081       3,221       3,603  
  TMS deferred revenue     (1,618 )     (1,601 )     (2,528 )     (3,694 )
  Other, net of cash flows from FMDS in 2012     (407 )     457       (3,041 )     1,140  
    Non-GAAP net operating cash usage   $ (7,852 )   $ (12,264 )   $ (32,361 )   $ (41,559 )
                                 

Contact: Dana Arvidson Investor Relations First Marblehead 800 Boylston Street, 34th FL Boston, MA 02199 617.638.2065

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Kohat University Teams Up with MindHYVE.ai for AI Learning

Updated Category News Views 283

Kohat University Partners with MindHYVE.ai to Innovate Education In a significant advancement for higher education in the region, Kohat University of Science & Technology (KUST) has established a strategic partnership with MindHYVE.ai™. This collaboration aims to introduce ArthurAI™, an advanced learning platform that utilizes agentic AI technology, into its academic...

Continue Reading
Lulus Enhances Market Reach Through Innovative Collaborations

Updated Category News Views 336

Expanding Market Reach Through Strategic Collaborations LOS ANGELES, A prominent player in the fashion industry, Lulus is taking significant steps to enhance its market presence and reach customers in new and exciting ways. By initiating collaborations with various platforms, Lulus is keen on tapping into emerging retail channels and broadening its accessibility....

Continue Reading
Explore Top Gardening Trends for Fall by Calloway's Nursery

Updated Category News Views 172

Embracing Fall Gardening Trends with Calloway's Nursery As the seasons change, so does the opportunity to refresh our gardens and outdoor spaces. Calloway's Nursery is here to help you embrace the beauty of fall gardening. The nursery’s offerings are tailored to inspire Texans to create vibrant and inviting spaces. Fantastic Fall Container Gardens Container gardens are...

Continue Reading
happyactually Strengthens Leadership with Dr. Andia Shahzadi

Updated Category News Views 119

happyactually Appoints Dr. Andia Shahzadi as Chief Medical Officer happyactually, an innovative wellbeing technology firm, proudly announces the elevation of Dr. Andia Shahzadi to the position of Chief Medical Officer and Founding Member of the team. This change marks a significant step in the company's aim to empower life-conscious individuals through scientifically...

Continue Reading
Surrozen to Showcase Innovations at Investor Conference Soon

Updated Category News Views 76

Surrozen Announces Presentation at Healthcare Investor Conference Recently, Surrozen, Inc. (Nasdaq: SRZN), a pioneering biotechnology company based in South San Francisco, revealed that its management team will be presenting at an upcoming healthcare investor conference. The company specializes in targeted therapeutics that focus on selectively modulating the Wnt pathway,...

Continue Reading